Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses is a research paper published in Immunity (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 CA016056
National Institutes of Health
Grant: R00CA175189
National Institutes of Health
Grant: R01AI100157
National Institutes of Health
Grant: R01CA121044
National Institutes of Health
Grant: T32 CA085183
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
Grant: CD80/CD86
NIAID NIH HHS
Grant: R01 AI155499
NCI NIH HHS
Grant: K99 CA175189
FWCI
0.79
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
Additional file 1 of Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
Additional file 2 of Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
Additional file 2 of Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer